11. Long‐term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side‐effects, improving patients' compliance. (1st January 2019) Authors: Marasca, C.; Masarà, A.; Annunziata, M.C.; Bettoli, V.; Luciano, M.A.; Fabbrocini, G. Journal: British journal of dermatology Issue: Volume 180:Number 4(2019) Page Start: 949 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. (1st January 2016) Authors: Fabbrocini, G.; Izzo, R.; Faggiano, A.; Del Prete, M.; Donnarumma, M.; Marasca, C.; Marciello, F.; Savastano, R.; Monfrecola, G.; Colao, A. Journal: Clinical and experimental dermatology Issue: Volume 41:Number 1(2016) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. (6th June 2015) Authors: Fabbrocini, G.; Izzo, R.; Faggiano, A.; Del Prete, M.; Donnarumma, M.; Marasca, C.; Marciello, F.; Savastano, R.; Monfrecola, G.; Colao, A. Journal: Clinical and experimental dermatology Issue: Volume 41:Number 1(2016) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb. (1st April 2019) Authors: Marasca, C.; Scala, E.; Di Caprio, R.; Raimondo, A.; Cacciapuoti, S.; Balato, A.; Fabbrocini, G. Journal: British journal of dermatology Issue: Volume 180:Number 4(2019) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb. (2nd January 2019) Authors: Marasca, C.; Scala, E.; Di Caprio, R.; Raimondo, A.; Cacciapuoti, S.; Balato, A.; Fabbrocini, G. Journal: British journal of dermatology Issue: Volume 180:Number 4(2019) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Quality of life in people living with patients suffering from hidradenitis suppurativa. (27th March 2020) Authors: Marasca, C.; Napolitano, M.; Monfrecola, G.; Masarà, A.; Annunziata, M.C.; Donnarumma, M.; Fabbrocini, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 7(2020) Page Start: e342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al. (31st May 2022) Authors: Martora, F.; Fabbrocini, G.; Nappa, P.; Marasca, C.; Patruno, C.; Scalvenzi, M.; Napolitano, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 9(2022) Page Start: e729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Reply to 'Cutaneous adverse effects of the available COVID‐19 vaccines in India: A questionnaire‐based study' by Bawane J et al. (30th June 2022) Authors: Potestio, L.; Genco, L.; Villani, A.; Marasca, C.; Fabbrocini, G.; Fornaro, L.; Ruggiero, A.; Martora, F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: e863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Small vessel vasculitis related to varicella‐zoster virus after Pfizer‐BioNTech COVID‐19 vaccine. (4th August 2021) Authors: Nastro, F.; Fabbrocini, G.; di Vico, F.; Marasca, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 11(2021) Page Start: e745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Telemedicine and support groups could be used to improve adherence to treatment and health‐related quality of life in patients affected by inflammatory skin conditions during the COVID‐19 pandemic. (1st August 2020) Authors: Marasca, C.; Ruggiero, A.; Fontanella, G.; Ferrillo, M.; Fabbrocini, G.; Villani, A. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 6(2020) Page Start: 749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗